Detalhe da pesquisa
1.
Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol;
23(9): 1180-1188, 2022 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35964621
2.
A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT-0701 MAPS phase 3 trial.
Int J Cancer;
150(11): 1889-1904, 2022 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35262190
3.
First-line carboplatin plus pemetrexed with pemetrexed maintenance in HIV-positive patients with advanced non-squamous non-small cell lung cancer: the phase II IFCT-1001 CHIVA trial.
Eur Respir J;
56(2)2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32444410
4.
Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial.
Lancet Oncol;
20(2): 239-253, 2019 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30660609
5.
MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial.
Br J Cancer;
120(4): 387-397, 2019 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30739911
6.
Cost-effectiveness of KRAS, EGFR and ALK testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study.
Eur Respir J;
51(3)2018 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29545318
7.
Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.
Lancet;
387(10026): 1405-1414, 2016 Apr 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26719230
8.
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT).
Lancet;
387(10026): 1415-1426, 2016 Apr 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26777916
9.
Association between lung cancer somatic mutations and occupational exposure in never-smokers.
Eur Respir J;
50(4)2017 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29074543
10.
Health-related quality of life in elderly patients with advanced non-small cell lung cancer comparing carboplatin and weekly paclitaxel doublet chemotherapy with monotherapy.
Eur Respir J;
48(3): 861-72, 2016 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27338193
11.
No impact of passive smoke on the somatic profile of lung cancers in never-smokers.
Eur Respir J;
45(5): 1415-25, 2015 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25745045
12.
Erlotinib versus carboplatin and paclitaxel in advanced lepidic adenocarcinoma: IFCT-0504.
Eur Respir J;
46(5): 1440-50, 2015 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26381515
13.
BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers.
Eur Respir J;
45(5): 1403-14, 2015 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25657019
14.
High-energy chirped- and divided-pulse Sagnac femtosecond fiber amplifier.
Opt Lett;
40(1): 89-92, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25531616
15.
Second-line therapy in elderly patients with advanced nonsmall cell lung cancer.
Eur Respir J;
43(1): 240-9, 2014 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24114964
16.
Study design and rationale for IFCT- 2203 TAXIO: A study that aims to evaluate the effectiveness of a first-line chemotherapy regimen without etoposide, combined with durvalumab, for patients with extensive disease small cell lung cancer.
Respir Med Res;
86: 101113, 2024 Apr 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38843598
17.
Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times.
Eur Respir J;
51(6)2018 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29929958
18.
Energy scaling of a nonlinear compression setup using passive coherent combining.
Opt Lett;
38(21): 4437-40, 2013 Nov 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24177113
19.
Femtosecond fiber chirped- and divided-pulse amplification system.
Opt Lett;
38(2): 106-8, 2013 Jan 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23454930
20.
Two-channel pulse synthesis to overcome gain narrowing in femtosecond fiber amplifiers.
Opt Lett;
38(24): 5430-3, 2013 Dec 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24343009